Abstract
Ibalizumab (Trogarzo (R); ibalizumab-uiyk) is the first monoclonal antibody to be approved for the treatment of HIV-1 infection. As a CD4-directed pos......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
